Salomon & Ludwin
RCUS icon

Salomon & Ludwin’s Arcus Biosciences RCUS Stock Holding History

Salomon & Ludwin’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.7K Hold
996
– – ﹤0.01% 815
2026
Q2 		$28.8K Sell
996
-59
-6% -$1.46K ﹤0.01% 880
2026
Q1 		$24.2K Buy
1,055
+257
+32% +$5.55K ﹤0.01% 951
2025
Q4 		$17.4K Hold
798
– – ﹤0.01% 1014
2025
Q3 		$10.7K Buy
+798
New +$8.3K ﹤0.01% 1258

Other funds holding RCUS

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Salomon & Ludwin's RCUS Position: Q3 2026 in Review

Salomon & Ludwin held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 996 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Salomon & Ludwin first reported a position in RCUS in Q3 2025 and has held it in 5 quarters since. The position peaked at $28.8K in Q2 2026. 111 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Salomon & Ludwin held 996 shares of Arcus Biosciences worth $25.7K as of Q3 2026.
  • Salomon & Ludwin left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #815 holding.
  • Salomon & Ludwin first reported a position in Arcus Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Arcus Biosciences position peaked at $28.8K in Q2 2026.
  • 111 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.